What Happened?
Burlingame, CA-based Inflammatix Appointed Tim Sweeney as Chief Executive Officer, Co-Founder
About the Company
Inflammatix, Inc. is a venture-backed startup located in the San Francisco Bay Area that is building novel diagnostics for acute infections and sepsis based on our unique immune biomarkers. Approximately $10 billion / year is spent trying to diagnose acute infections, but current technologies that focus on `finding the bug` are (1) slow and (2) effective in fewer than 30% of cases. Inflammatix has developed a statistically rigorous, extensively validated diagnostic method that `reads` the immune system. Our HostDx™ tests report clinically actionable information on the presence, type (bacterial or viral), and severity of infection in all patients. They have been extensively validated and published in top-tier medical journals. After this initial product, Inflammatix plans to develop and commercialize additional novel diagnostic tests to address significant unmet clinical needs.
About the Person
Tim Sweeney is Chief Executive Officer, Co-Founder at Inflammatix. Previously, Tim held various senior HR leadership roles in the industry.
Info Source
News
Short Profile